Drug Database
Back to search

Belgium· BE-AMP-SAM240712-00

Elidel 10 mg/g

A pimecrolimus product containing pimecrolimus, registered in Belgium by Viatris Healthcare. The same ATC class is registered in 13 of our 19 countries.

ATC D11AH02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedElidel 10 mg/gATCD11AH02REGISTER NO.BE-AMP-SAM240712-00PACKS LISTED5CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pimecrolimusAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pimecrolimus is registered in 13 of 19 countries.

Countries holding a registration under ATC D11AH02 (pimecrolimus), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search pimecrolimus products by name

Pimecrolimus · ATC D11AH02

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Pimecrolimus
Manufacturer
Viatris Healthcare
Country
Belgium (BE)
ATC code
D11AH02
ATC class
Pimecrolimus
Defined daily dose
20 mg, T
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 5

2 priced
  • be_apb
    1739259
    EUR 29.95
  • be_apb
    2198596
    EUR 46.83
  • be_apb
    1739267
  • be_apb
    0774463
  • be_apb
    7743784

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

217 interactions on record for pimecrolimus.

Graded by severity as the source publishes them — 9 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pimecrolimus against other medicinesHow interaction checks work

Pimecrolimus · interactions on record

217 records

  • 9 moderate
  • 83 minor
  • 125 info

Most severe, free to view

  • FostamatinibB02BX09moderate
  • EchinaceaD03AH02moderate
  • TemsirolimusL01EG01moderate
  • SirolimusL01EG04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pimecrolimus in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pimecrolimus products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Elidel
  • Bulgaria · Елидел
  • Cyprus · Elidel
  • Czechia · Elidel
  • Germany · Elidel
  • Denmark · Elidel
  • Estonia · Elidel
  • Spain · Elidel
  • Finland · Elidel
  • United Kingdom (Northern Ireland) · Elidel
  • Greece · Elidel
  • Croatia · Elidel
  • Hungary · Elidel
  • Iceland · Elidel
  • Italy · Elidel
  • Lithuania · Elidel
  • Luxembourg · Elidel
  • Latvia · Elidel
  • Malta · Elidel
  • Netherlands · Elidel
  • Norway · Elidel
  • Poland · Elidel
  • Portugal · Elidel
  • Romania · Elidel
  • Sweden · Elidel
  • Slovenia · Elidel
  • Slovakia · Elidel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b27dd9a2-4e5f-47e1-948b-db58ad5114b6
GET /v1/drugs/b27dd9a2-4e5f-47e1-948b-db58ad5114b6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Cream",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Elidel 10 mg/g",
  "name_fr": "Elidel 10 mg/g",
  "name_nl": "Elidel 10 mg/g",
  "amp_code": "SAM240712-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "10.0000",
    "40.0000",
    "50.0000",
    "10.0000",
    "0.2000",
    "40.0000"
  ],
  "pack_count": 5,
  "substances": [
    "Pimecrolimus",
    "Benzyl Alcohol",
    "Cetyl Alcohol",
    "Propylene Glycol",
    "Sodium Cetostearyl Sulfate",
    "Sodium Hydroxide",
    "Stearyl Alcohol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Pimecrolimus",
  "authorisation_numbers": [
    "BE240712"
  ]
}
API referenceMCP serverPlans

See everything about pimecrolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console